Effaclar A.Z. Gel Cream Daily Moisturiser for Breakouts & Ageing with 10% Azelaic Acid, Salicylic Acid, Hyaluronic Acid 40ml

A daily lightweight moisturiser, specifically formulated for adult, blemish-prone skin. Also suitable for those who may be prone to acne.

• Enriched with a potent tri-acid complex of 10% Azelaic Acid, Salicylic Acid and Hyaluronic Acid, this gel-cream immediately hydrates while delivering double efficacy against breakouts and ageing.


• For visibly clearer, more glowy skin in 7 days*.


• Gently exfoliates to reduce the appearance of adult spots and post-acne marks, while addressing fine lines & early wrinkles, and in one step.


• Fast-absorbing formula with clinically proven efficacy on all skin tones and suitable for sensitive skin.

*Clinical study, self-assessment, 81 subjects, application twice a day.

TRI-ACID COMPLEX FORMULA:

• 10% Azelaic Acid: Recognized for its gentle exfoliating efficacy, reducing the appearance of blemishes & post-acne marks. Contains anti-bacterial properties.


• Salicylic Acid: Gently & encourages cell turnover, to unclog pores & help prevent spots


• Hyaluronic Acid: Effectively plumps the skin and in doing so, reduces the appearance of fine lines & wrinkles, as well as improving skin hydration and texture.

Key Benefits:

• Visible results in 7 days*; 74% saw fewer adult spots 76% saw more radiant, glowy skin 69% saw more even skin tone 93% saw plumper skin**

*Clinical study, self-assessment, 81 subjects, application twice a day
**Clinical study, 42 subjects, application twice a day during 56 days

Specifically formulated for:
Specifically formulated for blemish-prone skin, that is also showing signs of ageing. Also suitable for those who may be prone to acne. Tested on & suitable for all skin tones. Also suitable for those who may be prone to acne. This is a cosmetic product. For medical conditions seek advice from your GP.

Recommended by dermatologists:
La Roche-Posay is the No. 1 Dermatologist recommended brand in the UK*  *Study of 78 Consultant Dermatologists Jan-April 2024.